These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38924646)

  • 21. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
    Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-Hydroxy-
    Krátký M; Štěpánková Š; Houngbedji NH; Vosátka R; Vorčáková K; Vinšová J
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alkynyl and β-ketophosphonates: Selective and potent butyrylcholinesterase inhibitors.
    Cavallaro V; Moglie YF; Murray AP; Radivoy GE
    Bioorg Chem; 2018 Apr; 77():420-428. PubMed ID: 29427857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
    Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
    Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
    Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors.
    Raza R; Saeed A; Arif M; Mahmood S; Muddassar M; Raza A; Iqbal J
    Chem Biol Drug Des; 2012 Oct; 80(4):605-15. PubMed ID: 22726458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S; Gökçe M; Orhan I; Sahin MF
    Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
    Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
    Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
    Akrami H; Mirjalili BF; Khoobi M; Nadri H; Moradi A; Sakhteman A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Sep; 84():375-81. PubMed ID: 25036795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
    Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant.
    de Souza GA; da Silva SJ; Del Cistia CN; Pitasse-Santos P; Pires LO; Passos YM; Cordeiro Y; Cardoso CM; Castro RN; Sant'Anna CMR; Kümmerle AE
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):631-637. PubMed ID: 30727776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New 3-
    Loh ZH; Kwong HC; Lam KW; Teh SS; Ee GCL; Quah CK; Ho ASH; Mah SH
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):627-639. PubMed ID: 33557647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
    Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel arylcarbamate-N-acylhydrazones derivatives as promising BuChE inhibitors: Design, synthesis, molecular modeling and biological evaluation.
    Yamazaki DAS; Rozada AMF; Baréa P; Reis EC; Basso EA; Sarragiotto MH; Seixas FAV; Gauze GF
    Bioorg Med Chem; 2021 Feb; 32():115991. PubMed ID: 33440318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.